Literature DB >> 18261991

Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells.

Stephanie Schwalm1, Frauke Döll, Isolde Römer, Svetlana Bubnova, Josef Pfeilschifter, Andrea Huwiler.   

Abstract

Sphingosine kinases (SK) catalyze the production of sphingosine-1-phosphate which in turn regulates cell responses such as proliferation and migration. Here, we show that exposure of the human endothelial cell line EA.hy 926 to hypoxia stimulates a increased SK-1, but not SK-2, mRNA, protein expression, and activity. This effect was due to stimulated SK-1 promoter activity which contains two putative hypoxia-inducible factor-responsive-elements (HRE). By deletion of one of the two HREs, hypoxia-induced promoter activation was abrogated. Furthermore, hypoxia upregulated the expression of HIF-1alpha and HIF-2alpha, and both contributed to SK-1 gene transcription as shown by selective depletion of HIF-1alpha or HIF-2alpha by siRNA. The hypoxia-stimulated SK-1 upregulation was functionally coupled to increased migration since the selective depletion of SK-1, but not of SK-2, by siRNAs abolished the migratory response. In summary, these data show that hypoxia upregulates SK-1 activity and results in an accelerated migratory capacity of endothelial cells. SK-1 may thus serve as an attractive therapeutic target to treat diseases associated with increased endothelial migration and angiogenesis such as cancer growth and progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18261991     DOI: 10.1016/j.bbrc.2008.01.132

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  37 in total

Review 1.  The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Authors:  Alphonse E Sirica
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-29       Impact factor: 46.802

2.  Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation.

Authors:  Stephanie Schwalm; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.

Authors:  Philip R Mayeux; Lee Ann MacMillan-Crow
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

4.  Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase.

Authors:  H Zhang; W Li; S Sun; S Yu; M Zhang; F Zou
Journal:  Cell Prolif       Date:  2012-01-30       Impact factor: 6.831

5.  Induction of gastrin expression in gastrointestinal cells by hypoxia or cobalt is independent of hypoxia-inducible factor (HIF).

Authors:  Lin Xiao; Suzana Kovac; Mike Chang; Arthur Shulkes; Graham S Baldwin; Oneel Patel
Journal:  Endocrinology       Date:  2012-05-16       Impact factor: 4.736

Review 6.  Sphingosine kinase regulation and cardioprotection.

Authors:  Joel S Karliner
Journal:  Cardiovasc Res       Date:  2008-11-18       Impact factor: 10.787

7.  Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.

Authors:  Jagadish Kummetha Venkata; Ningfei An; Robert Stuart; Luciano J Costa; Houjian Cai; Woodrow Coker; Jin H Song; Kiwana Gibbs; Terri Matson; Elizabeth Garrett-Mayer; Zhuang Wan; Besim Ogretmen; Charles Smith; Yubin Kang
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

8.  Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.

Authors:  Noriko Takuwa; Wa Du; Erika Kaneko; Yasuo Okamoto; Kazuaki Yoshioka; Yoh Takuwa
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

9.  Sphingosine kinase 2 mediates cerebral preconditioning and protects the mouse brain against ischemic injury.

Authors:  Lai Ming Yung; Ying Wei; Tao Qin; Yumei Wang; Charles D Smith; Christian Waeber
Journal:  Stroke       Date:  2011-10-06       Impact factor: 7.914

10.  CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.

Authors:  Christoph Tabeling; Hanpo Yu; Liming Wang; Hannes Ranke; Neil M Goldenberg; Diana Zabini; Elena Noe; Adrienn Krauszman; Birgitt Gutbier; Jun Yin; Michael Schaefer; Christoph Arenz; Andreas C Hocke; Norbert Suttorp; Richard L Proia; Martin Witzenrath; Wolfgang M Kuebler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.